Duova Multihaler (1) is a commercial drug that is prescribed in the form of Inhaler. The alternative uses of Duova Multihaler (1) have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Duova Multihaler (1). Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
While these are the most often observed Duova Multihaler (1) side effects, there are can be others also. These have been listed below. These side effects of Duova Multihaler (1) are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
Duova Multihaler (1)'s effect during pregnancy is Severe and Severe while nursing. Warnings related to Duova Multihaler (1)'s effects on the liver, heart and kidney, if any, have been listed below.
Duova Multihaler (1) is not recommended if you suffer from certain medical conditions as it can have adverse effects. Angioedema are examples of such conditions. Other conditions have been mentioned below in the Duova Multihaler (1) contraindications section.
Additionally, Duova Multihaler (1) may also adversely react with other medicines. See below for a complete list.
You should also be aware that Duova Multihaler (1) is safe while driving, and is addiction.
Duova Multihaler (1) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Based on research, the following side effects have been observed when Duova Multihaler (1) is used -
Severe
Moderate
Mild
Is the use of Duova Multihaler (1) safe for pregnant women?
Duova can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Duova Multihaler (1) safe during breastfeeding?
Taking Duova may lead to serious side effects if you are breastfeeding. Duova should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Duova Multihaler (1) on the Kidneys?
Duova rarely affects the kidneys.
What is the effect of Duova Multihaler (1) on the Liver?
The liver can be affected by Duova. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Duova only after medical advice.
What is the effect of Duova Multihaler (1) on the Heart?
There may be an adverse effect on the heart after taking Duova. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
Duova Multihaler (1) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Duova Multihaler (1) unless your doctor advises you to do so -
Is this Duova Multihaler (1) habit forming or addictive?
Duova Multihaler (1) does not cause addiction.
Interaction between Food and Duova Multihaler (1)
There isn't any research available on the side effects of taking Duova Multihaler (1) with food.
Interaction between Alcohol and Duova Multihaler (1)
Consumption of alcohol and Duova Multihaler (1) together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Perforomist® (formoterol fumarate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 595-596
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1207
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 117
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Spiriva® HandiHaler® (tiotropium bromide)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Braltus® (tiotropium bromide)